These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3971405)

  • 1. [Possibilities of influencing the hepatotoxicity of chemotherapeutics by the use of silymarin].
    Barton P; Krejcí V; Blazek M
    Cas Lek Cesk; 1985 Feb; 124(6):173-5. PubMed ID: 3971405
    [No Abstract]   [Full Text] [Related]  

  • 2. [Improvement of the hepatoprotective effect of silymarin when administered by injection].
    Rezábek K; Seda M; Procházka V
    Cas Lek Cesk; 1985 Feb; 124(6):170-2. PubMed ID: 3971404
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hepatotoxicity of antituberculosis drugs: practical implications for monitoring].
    Durand F; Bernuau J; Pessayre D
    Gastroenterol Clin Biol; 1998 Feb; 22(2):117-20. PubMed ID: 9762183
    [No Abstract]   [Full Text] [Related]  

  • 4. Acetaminophen hepatotoxicity in rats is attenuated by silybin dihemisuccinate.
    Campos R; Garrido A; Guerra R; Valenzuela A
    Prog Clin Biol Res; 1988; 280():375-8. PubMed ID: 3174702
    [No Abstract]   [Full Text] [Related]  

  • 5. [Silymarin in the prevention of hepatic damage by psychopharmacologic drugs. Experimental premises and clinical evaluations].
    Carrescia O; Benelli L; Saraceni F; Braga PC; Cagnetta G; Copponi V
    Clin Ter; 1980 Oct; 95(2):157-64. PubMed ID: 7471652
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of tests of the hepatoprotective effect of silymarin in experimental animals].
    Siblíková O; Trcka V; Vakocová H; Tichý M
    Cas Lek Cesk; 1985 Feb; 124(6):165-9. PubMed ID: 3971403
    [No Abstract]   [Full Text] [Related]  

  • 7. [Correction of adverse reactions in antimicrobial therapy of respiratory tract tuberculosis].
    Sukhanov DS; Kovalenko AL; Petrov AIu; Romantsov MG; Rybalkin SB
    Antibiot Khimioter; 2008; 53(5-6):51-7. PubMed ID: 19069183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Classification and diagnostic strategies of drug-induced hepatic disease].
    Li YM
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):445-6. PubMed ID: 15268822
    [No Abstract]   [Full Text] [Related]  

  • 9. [Silymarin, a membranotropic drug: clinical and experimental observations].
    De Martiis M; Fontana M; Sebastiani F; Parenzi A
    Clin Ter; 1977 May; 81(4):333-62. PubMed ID: 880785
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatotoxicity of antituberculous drugs.
    Rao NK; Wadia RS; Karve SR; Grant KB
    J Assoc Physicians India; 1982 May; 30(5):295-8. PubMed ID: 7169440
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hepatic drug monitoring in patients exposed to antitubercular treatment].
    Domínguez JP; Amenábar E; Mendoza F; Pivet H; Palacios L; Lagos A; Diaz N; Calderón J; Cardenas R; Pérez-Olea J
    Rev Med Chil; 1982 Aug; 110(8):733-7. PubMed ID: 7156604
    [No Abstract]   [Full Text] [Related]  

  • 12. [Assessment of hepatotoxicity of antitubercular drugs in patients with pulmonary tuberculosis abusing alcohol].
    Grymiński J; Lyczewska J; Styszewska H; Walczak J
    Gruzlica; 1969 Aug; 37(8):749-57. PubMed ID: 5352301
    [No Abstract]   [Full Text] [Related]  

  • 13. [Toxic occupational liver diseases. Therapeutic effects of silymarin].
    Boari C; Montanari FM; Galletti GP; Rizzoli D; Baldi E; Caudarella R; Gennari P
    Minerva Med; 1981 Oct; 72(40):2679-88. PubMed ID: 7290471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in the biochemical picture of chronic active hepatitis in the course of interrupted treatment with Legalon (author's transl)].
    Hanták I; Mikulecký M; Kratochvílová H
    Bratisl Lek Listy; 1980 Nov; 74(5):555-68. PubMed ID: 7448591
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatotoxicity of antituberculosis drugs.
    Kahana LM
    Thorax; 1996 Aug; 51(8):873-4. PubMed ID: 8795686
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of silymarin on carbon-tetrachloride- induced hepatotoxicity in rats].
    Dubin M; Groszmann RJ; Kravetz D; Costa JA; Cantor D
    Medicina (B Aires); 1976; 36(5):437-42. PubMed ID: 1004201
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical and experimental studies of liver damages in tuberculosis, with special reference to liver damages caused by antitubercular agents and the autonomic nervous factor].
    Homma Y
    Iryo; 1969 Apr; 23(4):482-501. PubMed ID: 5804545
    [No Abstract]   [Full Text] [Related]  

  • 18. Putative effect of silymarin on sawfly (Arge pullata)-induced hepatotoxicosis in sheep.
    Thamsborg SM; Jørgensen ; Brummerstedt E; Bjerregard J
    Vet Hum Toxicol; 1996 Apr; 38(2):89-91. PubMed ID: 8693692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Protective effect of silibinin on liver injury induced by antituberculosis drugs].
    Li J; Lin WF; Pan YY; Zhu XY
    Zhonghua Gan Zang Bing Za Zhi; 2010 May; 18(5):385-6. PubMed ID: 20510009
    [No Abstract]   [Full Text] [Related]  

  • 20. [The hepatotoxicity of antitubercular agents].
    Alegre Martín J; Fernández de Sevilla T
    An Med Interna; 1992 Nov; 9(11):523-5. PubMed ID: 1467398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.